The qRT-PCR validation of our findings confirms our microarray observations and found that SPON2 had high expression (approximately 18-fold increase) and MSMB had a moderate overexpression (approximately 2.6-fold increase) in tumor tissues compared to the adjacent normal tissues. This evidence concerns the gene SPON2 and neoplasm.